UnitedHealth Group's Stock Experiences Wild Fluctuations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4 days ago
0mins
Should l Buy UNH?
Source: CNBC
- Significant Price Drop: UnitedHealth Group's stock has plummeted over 60% since November 2024, primarily due to surging medical cost inflation and uncertainty from Washington, which has pressured margins and forced the company to lower its guidance.
- Executive Turmoil Impact: The killing of CEO Brian Thompson in New York has added another layer of uncertainty during an already fragile period for the company, negatively affecting investor confidence.
- Institutional Buying: Despite the challenges, large investment firms like Berkshire Hathaway have begun to build positions in the stock, signaling confidence in a potential turnaround and possibly providing price support.
- Positive Technical Signals: The stock has broken a two-year downtrend and is currently above key moving averages; while slightly overbought in the short term, market sentiment is improving, with expectations of a continued rise towards a target price of $375.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UNH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UNH
Wall Street analysts forecast UNH stock price to rise
19 Analyst Rating
16 Buy
3 Hold
0 Sell
Strong Buy
Current: 354.920
Low
330.00
Averages
397.82
High
444.00
Current: 354.920
Low
330.00
Averages
397.82
High
444.00
About UNH
UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
UnitedHealth Group Exceeds Quarterly Expectations
- Cost Control Success: UnitedHealth Group's medical benefit ratio for the quarter was 83.9%, lower than the expected 85.5%, enabling the company to achieve adjusted earnings per share of $7.23, significantly exceeding the forecast of $6.57, which boosts investor confidence in its cost management effectiveness.
- Strong Revenue Growth: The company reported total revenue of $111.7 billion for the quarter, surpassing Wall Street's estimate of $109.6 billion, indicating its competitive position in the market and sustained customer demand, potentially laying the groundwork for future business expansion.
- Regulatory Risks Unresolved: Despite the positive performance, ongoing investigations into UnitedHealth's billing practices, particularly regarding aggressive strategies in its Medicare Advantage operations, may lead to stricter regulations that could impact its operational model and revenue.
- Cautious Investor Sentiment: Following a 35% drop in stock price last year, investors remain cautious despite recent performance improvements, needing to observe whether the company can sustain its results to prove the stock's safety and investment value.
See More
UnitedHealth Group Reports Strong Quarterly Results Amid Ongoing Risks
- Strong Performance: UnitedHealth Group reported adjusted earnings per share of $7.23 for the quarter, exceeding analyst expectations of $6.57, showcasing the company's success in cost reduction, although the medical benefit ratio stood at 83.9%, down from 84.8% a year ago.
- Revenue Growth: The company achieved revenue of $111.7 billion this quarter, surpassing Wall Street's estimate of $109.6 billion, indicating an improvement in market performance that may attract more investor interest in the health insurance sector.
- Potential Risks: Despite the encouraging results, the company is under investigation regarding its billing practices, particularly Senator Chuck Grassley's concerns about its Medicare Advantage operations, which could lead to future regulatory restrictions impacting financial performance.
- Cautious Investment: Given the backdrop of a 35% decline in stock price over the past year, investors should remain cautious, waiting for the company to further prove the safety and long-term growth potential of its stock.
See More
UnitedHealth Group Reports Strong Q1 Results with 7% Share Surge
- Strong Earnings Beat: UnitedHealth Group reported Q1 revenue of $111.7 billion, reflecting a 2% year-over-year growth that exceeded estimates by $2.06 billion, with adjusted EPS of $7.23 surpassing expectations by $0.63, indicating robust recovery potential in the healthcare sector.
- Margin Expansion: The company improved its Medical Care Ratio to 83.9%, better than the expected 85.5%, representing a 90-basis-point increase from the prior year, showcasing management's confidence in future profitability and prompting an upward revision of the 2026 EPS outlook to over $18.25.
- AI Investment Initiative: UnitedHealth has committed $1.5 billion for AI investments in 2026 aimed at streamlining administrative workflows and claims processing, which is expected to enhance operational efficiency and strengthen competitive positioning through technological innovation.
- Stock Buyback Plan: The company plans to repurchase at least $2 billion of its common stock by the end of Q2 2026, further enhancing shareholder value, while also completing the sale of its Optum UK business, generating $400 million in net proceeds to support future growth strategies.
See More
UnitedHealth Group Shares Surge 30% in 30 Days
- Financial Recovery: UnitedHealth's Q1 revenue rose 2% year-over-year to $111.7 billion, with adjusted earnings per share at $7.23, slightly above last year's $7.20 but significantly up from $2.11 in Q4 2025, indicating recovery post-restructuring.
- Improved Medical Cost Management: The medical care ratio decreased to 83.9% in Q1 from 84.8% a year ago, attributed to strong cost management despite elevated utilization trends, which is crucial for enhancing profitability that was previously under pressure.
- Upgraded Full-Year Guidance: Management raised its 2026 adjusted earnings outlook to over $18.25 per share from $17.75, with the current stock price reflecting about 19 times the low end of this guidance, suggesting market confidence in future growth.
- Membership Attrition Concerns: Despite positive overall performance, UnitedHealth's membership dropped to 49.1 million in Q1 from 49.8 million at the end of 2025, with a notable decline of 965,000 seniors in Medicare Advantage, posing potential long-term growth challenges.
See More
UnitedHealth Raises Full-Year Earnings Outlook After Strong Q1
- Earnings Outlook Raised: UnitedHealth raised its 2026 adjusted earnings per share outlook from $17.75 to $18.25 after a strong Q1 report, indicating ongoing improvements in profitability, although the stock has surged 30%, it may still hold appeal for investors.
- Medical Care Ratio Improvement: The medical care ratio improved to 83.9% in Q1, down from 84.8% a year ago, reflecting effective medical cost management that alleviates profitability pressures faced last year, enhancing investor confidence.
- Health Insurance Business Growth: UnitedHealthcare's Q1 revenue rose to $86.3 billion from $84.6 billion year-over-year, contributing to overall profitability with operating earnings increasing from $5.2 billion to $5.7 billion and operating margin expanding from 6.2% to 6.6%.
- Optum Business Underperformance: Despite overall positive results, Optum's Q1 revenue was $63.7 billion, slightly down from the previous year, with operating earnings falling from $3.9 billion to $3.3 billion, indicating ongoing challenges in this segment.
See More
UnitedHealth and CVS Standardize Prior Authorizations
- Authorization Standardization: UnitedHealth (UNH) announced that over 50% of its prior authorization requests are now standardized for electronic submission, with expectations to exceed 70% by the end of 2026, significantly enhancing efficiency and reducing costs for healthcare providers.
- Industry Commitment Realized: CVS Health's Aetna has already standardized 88% of its prior authorization volume, surpassing industry goals, indicating the company's proactive efforts to enhance transparency and speed, ultimately improving patient experience.
- Policy Background Impact: The U.S. Department of Health and Human Services urged insurers to streamline cumbersome authorization processes last year, and the initiatives by UnitedHealth and CVS reflect the industry's commitment to improving customer experience in response to this policy.
- Future Outlook: UnitedHealthcare CEO Tim Noel emphasized that these changes will lay the groundwork for a more seamless electronic experience, showcasing the company's dedication to pursuing a modern, touchless authorization process that drives industry transformation.
See More
UnitedHealth Group Exceeds Quarterly Expectations
- Cost Control Success: UnitedHealth Group's medical benefit ratio for the quarter was 83.9%, lower than the expected 85.5%, enabling the company to achieve adjusted earnings per share of $7.23, significantly exceeding the forecast of $6.57, which boosts investor confidence in its cost management effectiveness.
- Strong Revenue Growth: The company reported total revenue of $111.7 billion for the quarter, surpassing Wall Street's estimate of $109.6 billion, indicating its competitive position in the market and sustained customer demand, potentially laying the groundwork for future business expansion.
- Regulatory Risks Unresolved: Despite the positive performance, ongoing investigations into UnitedHealth's billing practices, particularly regarding aggressive strategies in its Medicare Advantage operations, may lead to stricter regulations that could impact its operational model and revenue.
- Cautious Investor Sentiment: Following a 35% drop in stock price last year, investors remain cautious despite recent performance improvements, needing to observe whether the company can sustain its results to prove the stock's safety and investment value.
See More
UnitedHealth Group Reports Strong Quarterly Results Amid Ongoing Risks
- Strong Performance: UnitedHealth Group reported adjusted earnings per share of $7.23 for the quarter, exceeding analyst expectations of $6.57, showcasing the company's success in cost reduction, although the medical benefit ratio stood at 83.9%, down from 84.8% a year ago.
- Revenue Growth: The company achieved revenue of $111.7 billion this quarter, surpassing Wall Street's estimate of $109.6 billion, indicating an improvement in market performance that may attract more investor interest in the health insurance sector.
- Potential Risks: Despite the encouraging results, the company is under investigation regarding its billing practices, particularly Senator Chuck Grassley's concerns about its Medicare Advantage operations, which could lead to future regulatory restrictions impacting financial performance.
- Cautious Investment: Given the backdrop of a 35% decline in stock price over the past year, investors should remain cautious, waiting for the company to further prove the safety and long-term growth potential of its stock.
See More
UnitedHealth Group Reports Strong Q1 Results with 7% Share Surge
- Strong Earnings Beat: UnitedHealth Group reported Q1 revenue of $111.7 billion, reflecting a 2% year-over-year growth that exceeded estimates by $2.06 billion, with adjusted EPS of $7.23 surpassing expectations by $0.63, indicating robust recovery potential in the healthcare sector.
- Margin Expansion: The company improved its Medical Care Ratio to 83.9%, better than the expected 85.5%, representing a 90-basis-point increase from the prior year, showcasing management's confidence in future profitability and prompting an upward revision of the 2026 EPS outlook to over $18.25.
- AI Investment Initiative: UnitedHealth has committed $1.5 billion for AI investments in 2026 aimed at streamlining administrative workflows and claims processing, which is expected to enhance operational efficiency and strengthen competitive positioning through technological innovation.
- Stock Buyback Plan: The company plans to repurchase at least $2 billion of its common stock by the end of Q2 2026, further enhancing shareholder value, while also completing the sale of its Optum UK business, generating $400 million in net proceeds to support future growth strategies.
See More
UnitedHealth Group Shares Surge 30% in 30 Days
- Financial Recovery: UnitedHealth's Q1 revenue rose 2% year-over-year to $111.7 billion, with adjusted earnings per share at $7.23, slightly above last year's $7.20 but significantly up from $2.11 in Q4 2025, indicating recovery post-restructuring.
- Improved Medical Cost Management: The medical care ratio decreased to 83.9% in Q1 from 84.8% a year ago, attributed to strong cost management despite elevated utilization trends, which is crucial for enhancing profitability that was previously under pressure.
- Upgraded Full-Year Guidance: Management raised its 2026 adjusted earnings outlook to over $18.25 per share from $17.75, with the current stock price reflecting about 19 times the low end of this guidance, suggesting market confidence in future growth.
- Membership Attrition Concerns: Despite positive overall performance, UnitedHealth's membership dropped to 49.1 million in Q1 from 49.8 million at the end of 2025, with a notable decline of 965,000 seniors in Medicare Advantage, posing potential long-term growth challenges.
See More
UnitedHealth Raises Full-Year Earnings Outlook After Strong Q1
- Earnings Outlook Raised: UnitedHealth raised its 2026 adjusted earnings per share outlook from $17.75 to $18.25 after a strong Q1 report, indicating ongoing improvements in profitability, although the stock has surged 30%, it may still hold appeal for investors.
- Medical Care Ratio Improvement: The medical care ratio improved to 83.9% in Q1, down from 84.8% a year ago, reflecting effective medical cost management that alleviates profitability pressures faced last year, enhancing investor confidence.
- Health Insurance Business Growth: UnitedHealthcare's Q1 revenue rose to $86.3 billion from $84.6 billion year-over-year, contributing to overall profitability with operating earnings increasing from $5.2 billion to $5.7 billion and operating margin expanding from 6.2% to 6.6%.
- Optum Business Underperformance: Despite overall positive results, Optum's Q1 revenue was $63.7 billion, slightly down from the previous year, with operating earnings falling from $3.9 billion to $3.3 billion, indicating ongoing challenges in this segment.
See More
UnitedHealth and CVS Standardize Prior Authorizations
- Authorization Standardization: UnitedHealth (UNH) announced that over 50% of its prior authorization requests are now standardized for electronic submission, with expectations to exceed 70% by the end of 2026, significantly enhancing efficiency and reducing costs for healthcare providers.
- Industry Commitment Realized: CVS Health's Aetna has already standardized 88% of its prior authorization volume, surpassing industry goals, indicating the company's proactive efforts to enhance transparency and speed, ultimately improving patient experience.
- Policy Background Impact: The U.S. Department of Health and Human Services urged insurers to streamline cumbersome authorization processes last year, and the initiatives by UnitedHealth and CVS reflect the industry's commitment to improving customer experience in response to this policy.
- Future Outlook: UnitedHealthcare CEO Tim Noel emphasized that these changes will lay the groundwork for a more seamless electronic experience, showcasing the company's dedication to pursuing a modern, touchless authorization process that drives industry transformation.
See More
